Metabolex, Inc. Closes $8.6 Million Financing Round
11/5/2009 7:09:23 AM
More...
|
Metabolex, Inc. Announces Positive Phase 1 Clinical Trial Results of MBX-2982
10/13/2009 9:10:40 AM
More...
|
Metabolex, Inc. Announces Positive Results from Phase 2 Clinical Trial of MBX-8025 Compound Significantly Improves Multiple Lipid and Metabolic Parameters
11/18/2008 8:43:27 AM
More...
|
Metabolex, Inc. Announces Positive Results From Phase 1a Clinical Trial of MBX-2982 Results Presented at CODHy Conference
11/12/2008 8:28:59 AM
More...
|
Two Metabolex, Inc. Projects Recognized in Windhover's Top 10 Lists for Partnering Opportunities
11/3/2008 9:22:30 AM
More...
|
Metabolex, Inc. Announces Election of Robert L. Zerbe to Board of Directors
9/30/2008 10:18:40 AM
More...
|
Metabolex, Inc. Names Zhao, Martin to Executive Posts
7/9/2008 7:28:35 AM
More...
|
Metabolex, Inc. Completes Patient Enrollment in Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
6/16/2008 7:47:07 AM
More...
|
Metabolex, Inc. Appoints Donald Hill as Chief Financial Officer
4/14/2008 7:51:23 AM
More...
|
Metabolex, Inc. Initiates Phase 1 Trial of MBX-2982
3/26/2008 7:00:40 AM
More...
|
|